Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Galimberti

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Archives of Gerontology and Geriatrics|May 1, 2016
The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillationA Mazzone, M Bo, A Lucenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-upG Cervetti, S Galimberti, M Pelosini, et al.
Bone Marrow Transplantation|August 24, 1999
Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemiaS Galimberti, F Papineschi, A Carmignani, et al.
Bone Marrow Transplantation|February 3, 2004
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblingsF Papineschi, E Benedetti, S Galimberti, et al.
Leukemia & Lymphoma|April 11, 2003
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphomaR Riccioni, S Galimberti, G Cervetti, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 1, 1993
Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agentsP Pasquinelli, M Petrini, L Mattii, et al.
European Journal of Clinical Investigation|June 16, 2009
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cellsI Petrini, S Pacini, M Petrini, et al.
Bone Marrow Transplantation|January 27, 2004
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donorE Orciuolo, A Azzarà, G Bandini, et al.
Bone and Mineral|April 1, 1993
Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrationsG Abbiati, F Bartucci, A Longoni, et al.
Anticancer Research|August 26, 1998
Multidrug resistance related genes and p53 expression in human non small cell lung cancerS Galimberti, A Marchetti, F Buttitta, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Archives of Gerontology and Geriatrics|May 1, 2016
The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillationA Mazzone, M Bo, A Lucenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-upG Cervetti, S Galimberti, M Pelosini, et al.
Bone Marrow Transplantation|August 24, 1999
Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemiaS Galimberti, F Papineschi, A Carmignani, et al.
Bone Marrow Transplantation|February 3, 2004
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblingsF Papineschi, E Benedetti, S Galimberti, et al.
Leukemia & Lymphoma|April 11, 2003
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphomaR Riccioni, S Galimberti, G Cervetti, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 1, 1993
Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agentsP Pasquinelli, M Petrini, L Mattii, et al.
European Journal of Clinical Investigation|June 16, 2009
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cellsI Petrini, S Pacini, M Petrini, et al.
Bone Marrow Transplantation|January 27, 2004
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donorE Orciuolo, A Azzarà, G Bandini, et al.
Bone and Mineral|April 1, 1993
Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrationsG Abbiati, F Bartucci, A Longoni, et al.
Anticancer Research|August 26, 1998
Multidrug resistance related genes and p53 expression in human non small cell lung cancerS Galimberti, A Marchetti, F Buttitta, et al.
Pageof 7